Mitoxantrone Is Significantly Better Than Idarubicin At Improving The Outcome Of Children With Relapsed Acute Lymphoblastic Leukaemia
Links shared publicly online about this topic.
- 677total visits
Mitoxantrone Is Significantly Better Than Idarubicin At Improving The Outcome Of Children With Relapsed Acute Lymphoblastic Leukaemia
Although survival in children with acute lymphoblastic leukaemia has improved dramatically in the past few decades, this has not been the case for those who relapse. In a trial that compared the c
View full resource at medicalnewstoday.com
Tags: Children's Health
Most Recently Shared on December 5, 2010 at 2:05 pm By:
Mitoxantrone Is Significantly Better Than Idarubicin At Improving The Outcome Of Children With Relapsed Acute Lymphobl... http://mnt.to/3NwC
Also Shared By:
Advertisement
MNT Pediatrics News
@mnt_pediatrics
Mitoxantrone Is Significantly Better Than Idarubicin At Improving The Outcome Of Children With Relapsed Acute Lymphobl... http://mnt.to/3NwC
1 year ago...